Australian Pharmacist

Venous thromboembolism (VTE) is the third most common cardiovascular disease in the world. Every year, 30,000 people in Australia develop VTE, at a cost of $1.72 billion to the Australian health system.

This Royal Commission is an opportunity to improve how we care for our elderly, and release the chains holding pharmacists back from preventing inappropriate...

A study has found a pharmacy-driven protocol using nasal swabs to assess methicillin‑resistant Staphylococcus aureus (MRSA) in pneumonia cases holds promise for reducing unnecessary...

Antimicrobial medicines use declined in Australia from 2013 to 2018, but the country’s rate remains high by OECD standards, according to new research.

The future of pharmacy is bright, engaged and passionate, the search for the latest PSA MIMS Intern Pharmacist of the Year has revealed. Judges were...

Jennifer Cooke, the Editor of Australian Pharmacist, talks with Katherine Higgins, a pharmacist in South Perth, Western Australia.